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Accepted 30 November 2010AbstractObjectives: To present prenatal diagnosis and molecular cytogenetic characterization of de novo partial partial trisomy 21q (21q22.11/ qter) asso-
ciatedwith clinodactyly and hypoplasticmidphalanxof thefifthfingers,midfacehypoplasia, and an intracardiac echogenic focus onprenatal ultrasound.
Materials, Methods, and Results: A 34-year-old gravida 2, para 1 woman underwent amniocentesis at 20 weeks of gestation because of fetal
structural abnormalities on prenatal ultrasound. A level II ultrasound at 20weeks of gestation showed polyhydramnios, clinodactyly and hypoplastic
midphalanx of the fifth fingers, midface hypoplasia, and an intracardiac echogenic focus. Amniocentesis revealed an aberrant derivative chro-
mosome 9, or der(9). Parental karyotypes were normal. Spectral karyotyping (SKY) and fluorescence in situ hybridization (FISH) analyses revealed
that the der(9) contained a segment of chromosome 21 distal to chromosome 9q, and FISH analysis additionally showed that the distal subtelomeric
region of 9qwas not deleted.Array comparative genomic hybridization (aCGH) demonstrated a 14.8-Mb duplication of distal 21q encompassing the
Down syndrome critical region (DSCR) but no genomic imbalance in the distal euchromatic region of chromosome 9. The karyotype was
46,XX,der(9)t(9;21) (q34.3;q22.11)dn. PolymorphicDNAmarker analysis revealed thematernal origin of the aberrant chromosome. The pregnancy
was subsequently terminated. A malformed female fetus was delivered with a characteristic phenotype of Down syndrome.
Conclusion: SKY, FISH and aCGH are useful in prenatal investigation of the nature of a de novo aberrant derivative chromosome. Partial trisomy
21q encompassing the DSCR may present characteristic Down syndrome features on prenatal ultrasound.
Copyright  2011, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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493C.-P. Chen et al. / Taiwanese Journal of Obstetrics & Gynecology 50 (2011) 492e498Introduction (SKY) and array-based comparative genomic hybridizationPrenatal diagnosis of a de novo unbalanced translocation
may require molecular cytogenetic technologies, such as
fluorescence in situ hybridization (FISH), spectral karyotypingFig. 1. Prenatal ultrasound at 20 weeks of gestation shows (A) midface hypoplasia,
(C) an intracardiac echogenic focus (arrow).
Fig. 2. G-banded karyotype shows a derivative chromosome 9, or der(9(aCGH) to identify the nature of the de novo derivative
chromosome. We previously reported the usefulness of FISH,
SKY and aCGH in the identification of a de novo derivative
chromosome derived from an unbalanced translocation [1,2].(B) clinodactyly of the fifth finger with hypoplasia of midphalanx (arrow) and
). The proband’s karyotype is 46,XX,der(9)t(9;21)(q34.3;q22.11)dn.
Fig. 3. Spectral karyotyping (SKY) using 24-color SKY probes shows a der(9) derived from a translocation between chromosomes 9 and 21.
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cytogenetic characterization of de novo partial trisomy 21q
(21q22.11/ qter) derived from an unbalanced translocation
associated with some of features of Down syndrome, such as
clinodactyly and hypoplastic midphalanx of the fifth fingers,
midface hypoplasia and an intracardiac echogenic focus on
prenatal ultrasound.Fig. 4. Fluorescence in situ hybridization analysis using the 9q subtelomeric
bacterial artificial chromosome (BAC) clone probe RP11-417A4 (TxR-
labeled; red signal) (139,523,141e139,716,008 bp) (Build 36) and the 21q
subtelomeric BAC clone probe RP11-345F15 (FITC-labeled; green signal)
(45,593,807e45,808,641 bp) shows that the der(9) contains one red signal and
one green signal, and the green signal is distal to the red signal.Materials, methods and results
A 34-year-old gravida 2, para 1 woman was suggested to
undergo amniocentesis at 18 weeks of gestation because of
advanced maternal age, but she declined. Her husband was aged
34 years. She had a 2½-year-old healthy daughter. A level II
ultrasound at 20 weeks of gestation showed polyhydramnios
and some of the features of Down syndrome, such as clino-
dactyly and hypoplastic midphalanx of the fifth fingers, midface
hypoplasia, and an intracardiac echogenic focus (Fig. 1). The
woman decided to undergo amniocentesis. Amniocentesis
revealed an aberrant derivative chromosome 9, or der(9)
(Fig. 2). Chromosome preparations of the blood lymphocytes
from the parents revealed normal karyotypes. The derivative
chromosome was characterized by SKY using 24-color SKY
probes (Applied Spectral Imaging, Carlsbad, CA, USA) and by
FISH using DNA probe mixtures containing the 9q and 21q
subtelomeric probes. The SKY analysis revealed that the der(9)
contained a segment of chromosome 21 in the distal end of the
long arm of a chromosome 9 (Fig. 3). The FISH analysis showed
that the chromosome 21 segment in the distal end of the long arm
of der(9) was of 21q in origin, and the distal subtelomeric region
of 9q was not deleted (Fig. 4). Bacterial artificial chromosome
(BAC)-based aCGH [CMDX BAC-based aCGH CA3000 chips
(CMDX, Irvine, CA, USA)] demonstrated partial trisomy 21q
[arr cgh 21q22.11q22.3 (RP11-367F15/ RP11-100I21) 3]
(Fig. 5). Oligonucleotide-based aCGH [Oligo HDScan (CMDX,Irvine, CA, USA)] further demonstrated a 14.8-Mb duplication
of distal 21q [arr cgh 21q22.11q22.3 (32,110,552e
46,944,323)3] (NCBI build 36, March 2006) (Fig. 6). Whole
genome analysis by aCGH revealed no genomic imbalance in
the distal euchromatic region of chromosome 9 (Fig. 6). The
karyotype was 46,XX,der(9)t(9;21)(q34.3;q22.11)dn (Fig. 2).
Polymorphic DNA marker analysis revealed the maternal origin
of the aberrant chromosome. The parents opted to terminate the
Fig. 5. BAC based-array comparative genomic hybridization (aCGH) shows a distal 21q duplication [arr cgh 21q22.11q22.3 (RP11-367F15/ RP11-1000I21)3],
but no genomic imbalance in the distal euchromatic region of chromosome 9q.
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facial profile, hypertelorism, low-set ears, a depressed nasal
bridge, clinodactyly, hypoplastic midphalanx of the fifth fingers,
brachycephaly and epicanthic folds (Fig. 7).
Discussion
We have presented prenatal sonographic and molecular
cytogenetic characterization of a second-trimester fetus with
some clinical features of Down syndrome resulting from
a pure partial trisomy 21q (21q22.11/ qter) due to a de novo
unbalanced translocation. Down syndrome with an unbalanced
translocation involving a duplication of the Down syndrome
critical region (DSCR) is very rare and accounts for less than
1% of the cases with Down syndrome [3]. DSCR is the critical
region on chromosome 21 of which the duplication will be
sufficient to cause the Down syndrome phenotype. DSCR has
been narrowed down to 21q22 with an approximate length
of 5.4 Mb within 21q22.1-q22.3 [4,5]. Ronan et al. [6]additionally reported a 4.3-Mb region within 21q22.13-q22.2
with typical facial features of Down syndrome but no
congenital heart defects. Recently, Eggermann et al. [7] nar-
rowed down the DSCR in 21q22 with a 0.46-Mb duplication in
21q22 affecting the KCNE1 and DSCR1/RCAN1 genes.
To date, at least 38 cases of Down syndrome with pure
partial trisomy 21 have been reported [3,6e23]. Our case
manifested some of the clinical features of Down syndrome
similar to the cases reported by Nadal et al. [20] and Vaglio
et al. [23]. Nadal et al. [20] reported a 2-year-11-month-old
boy with pure partial trisomy 21q (21q22.1/ qter) due to an
intrachromosomal duplication, short stature, brachycephaly,
a flat face, oblique palpebral fissures, epicanthic folds, a flat
nasal bridge, a high palate, malformed and low-set ears, short
and broad hands with clinodactyly of the fifth fingers,
moderate mental retardation and delayed psychomotor devel-
opment. Vaglio et al. [23] reported a 4-year-10-month-old
girl with pure partial trisomy 21q (21q22.11/ qter) due to
a de novo intrachromosomal duplication, a flat broad face,
Fig. 6. Oligonucleotide-based aCGH shows (A) a 14.8-Mb distal 21q duplication [arr cgh 21q22.11q22.3 (32,110,552e46,944,323)3], and (B) no genomic
imbalance in the distal euchromatic region of chromosome 9q.
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fissures, epicanthic folds, blepharitis, brushfield spots, stra-
bismus, a wide mouth with downturned corners, a prominent
low lip, a narrow tongue and a short palate, but the diagnostic
criteria for mental retardation were not fulfilled.The present case manifested clinodactyly, midface hypo-
plasia, an intracardiac echogenic focus and hypoplastic mid-
phalanx of the fifth fingers on prenatal ultrasound. Prenatal
diagnosis of pure partial trisomy 21q associated with Down
syndrome is very rare. Lee et al. [22] reported prenatal diagnosis
Fig. 7. (A) Craniofacial profile and (B) the abnormal fifth finger with hypoplastic midphalanx (arrow) at birth.
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cryptic insertion (4;21)(q21;q22.1q22.3) inherited from the
carrier father. The mother was aged 32 years. The fetus had
a karyotype of 46,XX,der(4)ins(4;21)(q21;q22.13q22.2)pat. The
abnormal prenatal findings included a maternal serum screening
Down syndrome risk of 1:17 and a thick nuchal fold. The fetus
was delivered with clinical features of Down syndrome. Ronan
et al. [6] reported prenatal diagnosis of bilateral septated cystic
hygroma and hydrops in a fetus with pure trisomy 21q
(21q22.13/ q22.2) due to a 4.3-Mb intrachromosomal dupli-
cation of 21q22.13-q22.2 inherited from the mother who had the
facial gestalt of Down syndrome. Chorionic villus sampling
(CVS) at 12 weeks of gestation failed to identify the subtle
chromosome abnormalities. Postnatal reexamination of the CVS
samples using FISH showed a microduplication of 21q22.13-
q22.2 on one chromosome 21. The maternal DNA study using
aCGH revealed a 4.3-Mb gain of one copy of the same region.
The present case had a duplication of 21q22.11-qter
encompassing some genes associated with the pathophysi-
ology of Down syndrome such as DSCR1 (OMIM 602917),
DSCR2 (OMIM 605296), DSCR3 (OMIM 605298), DSCR4
(OMIM 604829), DSCR6 (OMIM 609892), DSCR8 or MMA1
(OMIM 613396), DSCR10, SIM2 (OMIM 600892) and
DYRK1A (OMIM 600855). DSCR1 or RCAN1 (regulator of
calcineurin 1) (gene map at 21q22.11-q22.2) protein is over-
expressed in the brain of the fetuses with Down syndrome.
DSCR1 protein interacts with calcineurin A, and over-
expression of DSCR1 will inhibit calcineurin-dependent gene
transcription through the inhibition of NFAT (OMIM 600489)
signaling pathway [24]. Ermak et al. [25] suggested that
overexpression of DSCR1 will inhibit calcineurin activity and
causes accumulation of hyperphosphorylated tau protein and
production of neurofibrillary tangles causing Alzheimer’s
disease. DYRK1A (dual-specificity tyrosine phosphorylation-
regulated kinase 1A) (gene map at 21q22.1) has been sug-
gested to be involved in the abnormal neurogenesis found in
Down syndrome [26]. Arron et al. [5] suggested that in Down
syndrome, with a 1.5-fold increase in the gene dosage within
DSCR, DSCR1 and DYRK1Awill cooperatively destabilize the
NFAT genetic regulatory circuit, leading to NFAT dysregula-
tion and abnormal phenotypes in Down syndrome. SIM2
(homolog of Drosophila single-minded 2) gene plays an
important role in Drosophila development and encodes a basic
helix-loop-helix protein that is a transcription factor in themidline development of CNS. Chen et al. [27] suggested that
human SIM gene is a candidate for facial and skull dysmor-
phology, brain abnormalities and mental retardation of Down
syndrome. In the mouse model, overexpression of Sim2 gene
contributes to the pathogenesis of Down syndrome [28,29].
In conclusion, aCGH is useful for rapid identification of the
genomic imbalance associated with a de novo derivative
chromosome, and SKY, FISH and aCGH are useful in prenatal
investigation of the nature of a de novo aberrant derivative
chromosome. Partial trisomy 21q encompassing the DSCR
may present characteristic Down syndrome features on
prenatal ultrasound.
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